Monitor for future Form 4 filings indicating actual option exercises or share dispositions. The vesting schedule suggests potential insider selling pressure in late 2026 and 2027 if share price exceeds exercise price.
Price Chart
Executive Summary
Noel Donnelly, a director of Radiopharm Theranostics Ltd, filed a Form 3 disclosing the grant of stock options for 8 million ordinary shares, with vesting dates in 2026 and 2027. The filing is a routine initial ownership disclosure and does not indicate any immediate change in beneficial ownership or corporate control.
Key Facts
- Form 3 filed by Noel Donnelly, a director of Radiopharm Theranostics Ltd, reporting initial beneficial ownership of stock options.
- Total of 8,000,000 ordinary shares underlying options: 2,666,667 granted with vesting on September 30, 2026, and 5,333,333 with vesting on September 30, 2027.
- Options were granted on December 16, 2024, with an exercise price of AUD 0.060 per share.
- No non-derivative securities (i.e., actual shares) are currently beneficially owned.
- Filing made on April 1, 2026, for a reporting date of March 18, 2026.
Financial Impact
Potential future dilution of 8 million shares if all options are exercised at AUD 0.060 per share (approx. USD 0.04 per share), but no immediate financial impact.
Risk Factors
- Future dilution risk upon option exercise, though minimal at current price levels.
- Limited transparency due to lack of current share ownership and absence of CIK/CUSIP identifiers in filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001213900-26-038788 |
| Document: 0001213900-26-038788-index.html | 0001213900-26-038788 |
| Document: 0001213900-26-038788.txt | 0001213900-26-038788 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 3, 2026 20w ago | 6-K | $0.0200 $0.0100 | ▼ −50.00% | ▼ −52.50% | $0.006660 (−66.70%) |
May 6, 2026 24w ago | 3 | $0.0200 $0.0100 | ▼ −50.00% | ▼ −53.83% | $0.006660 (−66.70%) |
Apr 23, 2026 26w ago | 6-K | $0.0200 $0.0100 | ▼ −50.00% | ▼ −55.02% | $0.006660 (−66.70%) |
Apr 16, 2026 27w ago | 6-K | $0.0200 $0.0100 | ▼ −50.00% | ▼ −57.05% | $0.006660 (−66.70%) |
Apr 8, 2026 28w ago | 6-K | $0.0200 $0.0100 | ▼ −50.00% | ▼ −60.46% | $0.006660 (−66.70%) |
Apr 7, 2026 29w ago | 6-K | $0.0200 $0.0100 | ▼ −50.00% | ▼ −63.27% | $0.006660 (−66.70%) |
Apr 1, 2026 29w ago | 3 | $0.0200 $0.0100 | ▼ −50.00% | ▼ −64.16% | $0.006660 (−66.70%) |
Mar 27, 2026 30w ago | 6-K | $0.0200 $0.0200 | · 0.00% | ▼ −16.07% | $0.006660 (−66.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers